Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Res Social Adm Pharm. 2019 Dec 9;16(8):1136–1139. doi: 10.1016/j.sapharm.2019.12.006

Figure 2.

Figure 2.

Expected Trend for the Number of Prescriptions on Efinaconazole and Tavaborole per 100,000 Medicare Beneficiaries

NOTES:

Predicted with Interrupted Time-Series Analyses from dates July 2014 to December 2016. Solid lines indicate observed trends with Super Bowl advertisements while dotted lines indicate trends that would have been expected if the slope had not changed following the Super Bowl advertisements.